Previous close | 8.00 |
Open | 8.05 |
Bid | 0.00 x 800 |
Ask | 0.00 x 1200 |
Day's range | 7.93 - 8.22 |
52-week range | 6.25 - 42.57 |
Volume | |
Avg. volume | 371,498 |
Market cap | 386.909M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.04 |
Earnings date | 10 May 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 17.00 |
MENLO PARK, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced plans to participate in the upcoming Piper Sandler Virtual Ophthalmology & Diabetes Symposium. Sight Sciences’ management is scheduled to participate in a fireside chat Monday, May 23, 2022, at 10:00am PT. Interested parties may access a live and archived webcast of t
MENLO PARK, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today reported financial results for the quarter ended March 31, 2022. Recent Business Highlights Generated first quarter 2022 total revenue of $14.9 million, an increase of 72% compared to the prior year periodIncreased the number of facilities ordering the OMNI® Surgical System fr
A look at the shareholders of Sight Sciences, Inc. ( NASDAQ:SGHT ) can tell us which group is most powerful. Large...